Trial Outcomes & Findings for Assess the Feasibility of Cone Beam CT to Localize Liver Metastases Immediately Prior to Radiotherapy (NCT NCT00600613)

NCT ID: NCT00600613

Last Updated: 2015-05-07

Results Overview

Assess the feasibility of using a new imaging technique called "cone beam imaging" to localize a liver tumor immediately prior to external beam radiotherapy.

• Recruitment status: COMPLETED
• Study phase: NA
• Target enrollment: 6 participants
• Primary outcome timeframe: Up to 2 hours
• Results posted on: 2015-05-07

Participant Flow

Participant milestones

Measure	Patients Going for Treatment of Liver Metastases With RT Patients going for treatment of liver metastases with radiation therapy.
Overall Study STARTED	6
Overall Study COMPLETED	5
Overall Study NOT COMPLETED	1

Reasons for withdrawal

Measure	Patients Going for Treatment of Liver Metastases With RT Patients going for treatment of liver metastases with radiation therapy.
Overall Study Protocol Deviation	1

Baseline Characteristics

Assess the Feasibility of Cone Beam CT to Localize Liver Metastases Immediately Prior to Radiotherapy

Baseline characteristics by cohort

Measure	Patients Going for Treatment of Liver Metastases With RT n=6 Participants Patients going for treatment of liver metastases with radiation therapy.
Age, Categorical <=18 years	0 Participants n=5 Participants
Age, Categorical Between 18 and 65 years	3 Participants n=5 Participants
Age, Categorical >=65 years	3 Participants n=5 Participants
Sex: Female, Male Female	1 Participants n=5 Participants
Sex: Female, Male Male	5 Participants n=5 Participants

PRIMARY outcome

Timeframe: Up to 2 hours

Assess the feasibility of using a new imaging technique called "cone beam imaging" to localize a liver tumor immediately prior to external beam radiotherapy.

Outcome measures

Measure	Patients Going for Treatment of Liver Metastases With RT n=5 Participants Patients going for treatment of liver metastases with radiation therapy.
Number of Participants Eligible for Cone Beam Tumor Localization"	5 participants

Adverse Events

Patients Going for Treatment of Liver Metastases With RT

Serious events: 0 serious events

Other events: 0 other events

Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Dr. Yoshiya Yamada

Memorial Sloan Kettering Cancer Center

Phone: 212-639-2950

Email: yamadaj@mskcc.org

Results disclosure agreements

• Principal investigator is a sponsor employee
• Publication restrictions are in place